Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
Access event page
Join Dr. Sergio Leonardi, Prof. Pascal Vranckx and Prof. Kurt Huber.
Free for everyone
Direct oral anticoagulants are increasingly used in patients with atrial fibrillation for the prevention of stroke and systemic embolism. A significant proportion of patients with atrial fibrillation has or will develop concomitant ischaemic heart disease. The choice of the most appropriate antithrombotic treatment strategy in this setting can be challenging due to the concurrent risk of ischaemic and haemorrhagic complications.
Dr. Sergio Leonardi, FESCFondazione Irccs Policlinico S.MatteoCardiology DepartmentPavia, Italy
Prof. Pascal VranckxCardiac Critical Care ServicesHartcentrum HasseltHasselt, Belgium
Prof. Kurt HuberCardiology and Intensive Care MedicineWilhelminenhospitalVienna, Austria
This webinar addresses cardiologists and cardiologists in training specialised in internal medicine or neurology, and those wishing to update their scientific knowledge on the topic.
During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.
An application has been made to the EACCME® for CME accreditation of this event.
The webinar is available on PC and tablets. The use of a smartphone is not recommended.
To answer the MCQs during the live event, you must allow pop-up windows on your device.
A high-speed Internet connection is required (minimum 2 Mbps).
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 Biot
06903, Sophia Antipolis, FR
This programme is supported by Bristol-Myers Squibb and Pfizer Alliance in the form of an educational grant. The scientific programme has not been influenced in any way by its sponsors.
Our mission: To reduce the burden of cardiovascular disease.
© 2020 European Society of Cardiology. All rights reserved.